AES
50
3
BMY
30
2
CVX
17
3
GT
50
5
BIIB
42
2
DVN
16
2
XRX
46
-7
ABBV
46
6
MTCH
55
-4
AEE
48
-2
GIS
47
3
MDLZ
36
2
VZ
30
5
SPG
50
2
PCAR
42
2
RIG
40
5
EXPE
81
-2
XOM
36
3
ADBE
52
-2
BEN
37
3
AES
50
3
BMY
30
2
CVX
17
3
GT
50
5
BIIB
42
2
DVN
16
2
XRX
46
-7
ABBV
46
6
MTCH
55
-4
AEE
48
-2
GIS
47
3
MDLZ
36
2
VZ
30
5
SPG
50
2
PCAR
42
2
RIG
40
5
EXPE
81
-2
XOM
36
3
ADBE
52
-2
BEN
37
3
Financhill
Back

abrdn Life Sciences Investors Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36

HQL
abrdn Life Sciences Investors

Last Price:
$13.09
Seasonality Move:
2.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Could This Stock Under $5 Be Your Biggest Opportunity?

Click here to learn more.

abrdn Life Sciences Investors Stock Forecast

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 3.1% based on the past 26 years of stock performance.
  • abrdn Life Sciences Investors has risen higher in 13 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is abrdn Life Sciences Investors Stock Undervalued?
    The current abrdn Life Sciences Investors [HQL] share price is $13.12. The Score for HQL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • HQL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will abrdn Life Sciences Investors Stock Go Up Next Year?

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 3.1% based on the past 26 years of stock performance.

abrdn Life Sciences Investors Stock Rating

Sell
36
abrdn Life Sciences Investors (HQL) is a Sell

Is abrdn Life Sciences Investors overpriced?

  • abrdn Life Sciences Investors has risen higher in 13 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

abrdn Life Sciences Investors Stock Price History

Is HQL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HQL is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Sector:
Type:
stock
Website:
abrdnhql.com

52-Week Data

52-Week High:
15.90
52-Week Low:
12.76

Prediction Charts

Market Cap:
0
Price in USD:
13.12
Volume:
242K
Beta:
0.96

Technical Analysis

SMA50:
14.27
SMA100:
14.72
SMA200:
14.33
52-Wk Change:
-2.53%

Stock Predictions

  • Is abrdn Life Sciences Investors stock public?
    Yes, abrdn Life Sciences Investors is a publicly traded company.
  • What is the abrdn Life Sciences Investors stock quote today?
    The abrdn Life Sciences Investors stock price is 13.12 USD today.
  • How to buy abrdn Life Sciences Investors stock online?
    You can buy abrdn Life Sciences Investors shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-11 14.19 14.19 14.27 14.10
Dec-12 14.12 13.98 14.12 13.96
Dec-13 13.97 13.84 13.97 13.81
Dec-16 13.89 13.80 13.96 13.76
Dec-17 13.86 13.87 13.90 13.81
Dec-18 13.87 13.34 13.92 13.34
Dec-19 13.40 13.15 13.53 13.11
Dec-20 13.16 13.50 13.54 13.16
Dec-23 13.50 13.47 13.53 13.34
Dec-24 13.55 13.60 13.66 13.47
Dec-26 13.59 13.62 13.67 13.52
Dec-27 13.56 13.50 13.65 13.40
Dec-30 13.45 13.14 13.49 13.11
Dec-31 13.16 13.12 13.34 13.05

abrdn Life Sciences Investors Earnings

Data Unavailable

abrdn Life Sciences Investors Forecast Revenue Growth

Data Unavailable

* abrdn Life Sciences Investors stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.